{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T02:04:49Z","timestamp":1777341889226,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-024-04322-z","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T20:43:15Z","timestamp":1734640995000},"page":"1895-1905","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison between the effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and their combination on mortality in maintenance dialysis patients: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"57","author":[{"given":"Omar","family":"Elkoumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Elkoumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam Khaled","family":"Elbairy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Irfan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Beddor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa Adel T.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar K.","family":"Habib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada Ibrahim","family":"Hendi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayah","family":"Abdulgadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bandar","family":"Alawlaqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed K.","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"4322_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1523-1755.2003.00321.x","volume":"64","author":"K Jc","year":"2003","unstructured":"Jc K et al (2003) Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int 64:6. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00321.x","journal-title":"Kidney Int"},{"key":"4322_CR2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01960309","author":"E Ritz","year":"2009","unstructured":"Ritz E, Bommer J (2009) Cardiovascular problems on hemodialysis: current deficits and potential improvement. Clin J Am Soc Nephrol. https:\/\/doi.org\/10.2215\/CJN.01960309","journal-title":"Clin J Am Soc Nephrol"},{"issue":"16","key":"4322_CR3","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1001\/jama.2009.1488","volume":"302","author":"DJ de Jager","year":"2009","unstructured":"de Jager DJ et al (2009) Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 302(16):1782\u20131789. https:\/\/doi.org\/10.1001\/jama.2009.1488","journal-title":"JAMA"},{"issue":"7","key":"4322_CR4","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1097\/01.ASN.0000019641.41496.1E","volume":"13","author":"JC Longenecker","year":"2002","unstructured":"Longenecker JC et al (2002) traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE study. J Am Soc Nephrol 13(7):1918\u20131927. https:\/\/doi.org\/10.1097\/01.ASN.0000019641.41496.1E","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"4322_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1046\/j.1523-1755.2000.00173.x","volume":"58","author":"AK Cheung","year":"2000","unstructured":"Cheung AK et al (2000) Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58(1):353\u2013362. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00173.x","journal-title":"Kidney Int"},{"issue":"33","key":"4322_CR6","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B et al (2018) 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J 39(33):3021\u20133104. https:\/\/doi.org\/10.1093\/eurheartj\/ehy339","journal-title":"Eur Heart J"},{"issue":"15","key":"4322_CR7","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1056\/NEJM199604113341502","volume":"334","author":"G Maschio","year":"1996","unstructured":"Maschio G et al (1996) Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. the angiotensin-converting-enzyme inhibition in progressive renal Insufficiency study group. N Engl J Med 334(15):939\u2013945. https:\/\/doi.org\/10.1056\/NEJM199604113341502","journal-title":"N Engl J Med"},{"issue":"9","key":"4322_CR8","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/imj.13971","volume":"48","author":"H Lee","year":"2018","unstructured":"Lee H et al (2018) End-stage renal disease patients using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of mortality: a Taiwanese Nationwide cohort study. Intern Med J 48(9):1123\u20131132. https:\/\/doi.org\/10.1111\/imj.13971","journal-title":"Intern Med J"},{"issue":"16","key":"4322_CR9","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1093\/eurheartj\/ehs108","volume":"33","author":"F Ruschitzka","year":"2012","unstructured":"Ruschitzka F, Taddei S (2012) Angiotensin-converting enzyme inhibitors: first-line agents in cardiovascular protection? Eur Heart J 33(16):1996\u20131998. https:\/\/doi.org\/10.1093\/eurheartj\/ehs108","journal-title":"Eur Heart J"},{"issue":"11","key":"4322_CR10","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1016\/j.jacc.2003.12.051","volume":"43","author":"K Yasunari","year":"2004","unstructured":"Yasunari K, Maeda K, Watanabe T, Nakamura M, Yoshikawa J, Asada A (2004) Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy. J Am Coll Cardiol 43(11):2116\u20132123. https:\/\/doi.org\/10.1016\/j.jacc.2003.12.051","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"4322_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/s0272-6386(99)70071-5","volume":"34","author":"EM de Cavanagh","year":"1999","unstructured":"de Cavanagh EM et al (1999) Higher levels of antioxidant defenses in enalapril-treated versus non-enalapril-treated hemodialysis patients. Am J Kidney Dis 34(3):445\u2013455. https:\/\/doi.org\/10.1016\/s0272-6386(99)70071-5","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"4322_CR12","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1093\/ndt\/gfl293","volume":"21","author":"A Takahashi","year":"2006","unstructured":"Takahashi A et al (2006) Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis\u2014a randomized study. Nephrol Dial Transplant 21(9):2507\u20132512. https:\/\/doi.org\/10.1093\/ndt\/gfl293","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"4322_CR13","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1053\/ajkd.2002.36340","volume":"40","author":"S Efrati","year":"2002","unstructured":"Efrati S et al (2002) ACE inhibitors and survival of hemodialysis patients. Am J Kidney Dis 40(5):1023\u20131029. https:\/\/doi.org\/10.1053\/ajkd.2002.36340","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"4322_CR14","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1093\/ndt\/gfp767","volume":"25","author":"JH Cho","year":"2010","unstructured":"Cho JH et al (2010) Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study. Nephrol Dial Transplant 25(6):1964\u20131973. https:\/\/doi.org\/10.1093\/ndt\/gfp767","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"4322_CR15","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/ndt\/gfn421","volume":"24","author":"I Kolesnyk","year":"2008","unstructured":"Kolesnyk I, Noordzij M, Dekker FW, Boeschoten EW, Krediet RT (2008) A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients. Nephrol Dial Transplant 24(1):272\u2013277. https:\/\/doi.org\/10.1093\/ndt\/gfn421","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"4322_CR16","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1681\/ASN.2018040443","volume":"29","author":"V Saglimbene","year":"2018","unstructured":"Saglimbene V et al (2018) The long-term impact of renin-angiotensin system (RAS) inhibition on cardiorenal outcomes (LIRICO): a randomized, controlled trial. JASN 29(12):2890\u20132899. https:\/\/doi.org\/10.1681\/ASN.2018040443","journal-title":"JASN"},{"key":"4322_CR17","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. The BMJ 339:2535. https:\/\/doi.org\/10.1136\/bmj.b2535","journal-title":"The BMJ"},{"key":"4322_CR18","doi-asserted-by":"publisher","unstructured":"J. P. T. Higgins et al., Eds., Cochrane Handbook for Systematic Reviews of Interventions, 1st ed. Wiley, 2019. https:\/\/doi.org\/10.1002\/9781119536604.","DOI":"10.1002\/9781119536604"},{"issue":"4","key":"4322_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.13105\/wjma.v5.i4.80","volume":"5","author":"C Luchini","year":"2017","unstructured":"Luchini C, Stubbs B, Solmi M, Veronese N (2017) Assessing the quality of studies in meta-analyses: advantages and limitations of the Newcastle Ottawa Scale. WJMA 5(4):80. https:\/\/doi.org\/10.13105\/wjma.v5.i4.80","journal-title":"WJMA"},{"issue":"4","key":"4322_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/XEB.0000000000000141","volume":"16","author":"L Furuya-Kanamori","year":"2018","unstructured":"Furuya-Kanamori L, Barendregt JJ, Doi SAR (2018) A new improved graphical and quantitative method for detecting bias in meta-analysis. Int J Evid Based Healthc 16(4):195\u2013203. https:\/\/doi.org\/10.1097\/XEB.0000000000000141","journal-title":"Int J Evid Based Healthc"},{"issue":"2","key":"4322_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s40620-016-0340-3","volume":"30","author":"JI Shen","year":"2017","unstructured":"Shen JI, Saxena AB, Montez-Rath ME, Leng L, Chang TI, Winkelmayer WC (2017) Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis. J Nephrol 30(2):281\u2013288. https:\/\/doi.org\/10.1007\/s40620-016-0340-3","journal-title":"J Nephrol"},{"issue":"6","key":"4322_CR22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1159\/000482013","volume":"46","author":"R Kido","year":"2017","unstructured":"Kido R, Akizawa T, Fukagawa M, Onishi Y, Yamaguchi T, Fukuhara S (2017) Interactive effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers or their combination on survival of hemodialysis patients. Am J Nephrol 46(6):439\u2013447. https:\/\/doi.org\/10.1159\/000482013","journal-title":"Am J Nephrol"},{"issue":"9","key":"4322_CR23","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/ki.2011.228","volume":"80","author":"KE Chan","year":"2011","unstructured":"Chan KE, Ikizler TA, Gamboa JL, Yu C, Hakim RM, Brown NJ (2011) Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients. Kidney Int 80(9):978\u2013985. https:\/\/doi.org\/10.1038\/ki.2011.228","journal-title":"Kidney Int"},{"issue":"1","key":"4322_CR24","doi-asserted-by":"publisher","first-page":"2313173","DOI":"10.1080\/0886022X.2024.2313173","volume":"46","author":"SH Kang","year":"2024","unstructured":"Kang SH, Kim GO, Kim BY, Son EJ, Do JY (2024) Effect of angiotensin-converting enzyme inhibitors versus that of angiotensin receptor blockers on survival in patients undergoing hemodialysis: a nationwide observational cohort study. Ren Fail 46(1):2313173. https:\/\/doi.org\/10.1080\/0886022X.2024.2313173","journal-title":"Ren Fail"},{"issue":"6","key":"4322_CR25","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1159\/000452590","volume":"41","author":"TI Shireman","year":"2016","unstructured":"Shireman TI, Mahnken JD, Phadnis MA, Ellerbeck EF, Wetmore JB (2016) Comparative effectiveness of renin-angiotensin system antagonists in maintenance dialysis patients. Kidney Blood Press Res 41(6):873\u2013885. https:\/\/doi.org\/10.1159\/000452590","journal-title":"Kidney Blood Press Res"},{"issue":"3","key":"4322_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000424","volume":"94","author":"C-K Wu","year":"2015","unstructured":"Wu C-K et al (2015) Effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in dialysis patients: a nationwide data survey and propensity analysis. Medicine 94(3):e424. https:\/\/doi.org\/10.1097\/MD.0000000000000424","journal-title":"Medicine"},{"issue":"1","key":"4322_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12882-015-0162-x","volume":"16","author":"JL Gamboa","year":"2015","unstructured":"Gamboa JL, Pretorius M, Sprinkel KC, Brown NJ, Ikizler TA (2015) Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis \u2013 a randomized cross-over study. BMC Nephrol 16(1):167. https:\/\/doi.org\/10.1186\/s12882-015-0162-x","journal-title":"BMC Nephrol"},{"issue":"5","key":"4322_CR28","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1053\/j.ajkd.2015.10.011","volume":"67","author":"X Xie","year":"2016","unstructured":"Xie X et al (2016) Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a bayesian network meta-analysis of randomized clinical trials. Am J Kidney Dis 67(5):728\u2013741. https:\/\/doi.org\/10.1053\/j.ajkd.2015.10.011","journal-title":"Am J Kidney Dis"},{"issue":"5 Suppl 3","key":"4322_CR29","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32(5 Suppl 3):S112-119. https:\/\/doi.org\/10.1053\/ajkd.1998.v32.pm9820470","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"4322_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1046\/j.1525-139X.1999.00006.x","volume":"12","author":"MJ Sarnak","year":"1999","unstructured":"Sarnak MJ, Levey AS (1999) Epidemiology of cardiac disease in dialysis patients. Semin Dial 12(2):69\u201376. https:\/\/doi.org\/10.1046\/j.1525-139X.1999.00006.x","journal-title":"Semin Dial"},{"issue":"5","key":"4322_CR31","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1001\/jamainternmed.2014.348","volume":"174","author":"J Cheng","year":"2014","unstructured":"Cheng J et al (2014) Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis. JAMA Intern Med 174(5):773. https:\/\/doi.org\/10.1001\/jamainternmed.2014.348","journal-title":"JAMA Intern Med"},{"issue":"21","key":"4322_CR32","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.jacc.2010.03.105","volume":"56","author":"G Cice","year":"2010","unstructured":"Cice G et al (2010) Effects of telmisartan added to angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure. J Am Coll Cardiol 56(21):1701\u20131708. https:\/\/doi.org\/10.1016\/j.jacc.2010.03.105","journal-title":"J Am Coll Cardiol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04322-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-024-04322-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04322-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T14:12:53Z","timestamp":1746281573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-024-04322-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["4322"],"URL":"https:\/\/doi.org\/10.1007\/s11255-024-04322-z","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and\u00a0Consent for publication"}},{"value":"This article does not contain any studies with human or\u00a0animal subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}}]}}